Moraxella catarrhalis: Clinical significance, antimicrobial susceptibility and BRO beta-lactamases

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 4, 1998, Pages 219-234

  McGregor, K ^a   Chang, B J ^a   Mee, B J ^a   Riley, T V ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; HOSPITAL INFECTION; HUMAN; MORAXELLA CATARRHALIS; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; UPPER RESPIRATORY TRACT;

EID: 0031817912     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01699978     Document Type: Review

References (227)

1. Pfister LE, Gallagher MV, Potterfield TG, Brown DW: Neisseria catarrhalis bacteremia with meningitis. Journal of the American Medical Association (1965) 193:399-401
2. Vaneechoutte M, Verschraegen G, Claeys G, Weise B, Van Den Abeele AM: Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of Moraxella catarrhalis from sputum. Journal of Clinical Microbiology (1990) 28:2674-2680
3. Murphy TF: Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiological Reviews (1996) 60:267-279
4. Murphy TF, Sethi S: Bacterial infection in chronic obstructive pulmonary disease. American Review of Respiratory Disease (1992) 146:1067-1083.
5. McLeod DT, Ahmad F, Capewell S, Croughan MJ, Calder MA, Seaton A: Increase in bronchopulmonary infection due to Branhamella catarrhalis. British Medical Journal (1986) 292:1103-1105
6. Nicotra B, Rivera M, Luman JI, Wallace RJ: Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Archives of Internal Medicine (1986) 146:890-893
7. Ninane G, Joly J, Kraytman M: Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. British Medical Journal (1978) i: 276-278
8. Aitken JM, Thornley PE: Isolation of Branhamella catarrhalis from sputum and tracheal aspirate. Journal of Clinical Microbiology (1983) 18:1262-1263
9. Hager H, Verghese A, Alvarez S, Berk SL: Branhamella catarrhalis respiratory infections. Reviews of Infectious Diseases (1987) 9:1140-1149
10. Darelid J, Lofgren S, Malmvall BE: Erythromycin treatment is beneficial for longstanding Moraxella catarrhalis associated cough in children. Scandinavian Journal of Infectious Diseases (1993) 25:323-329
11. Choo PW, Gantz NM: Branhamella catarrhalis pneumonia with bacteremia. Southern Medical Journal (1989) 82:1317-1318
12. Wallace MR, Oldfield EC: Moraxella (Branhamella) catarrhalis bacteremia. Archives of Internal Medicine (1990) 150:1332-1334
13. Collazos J, de Miguel J, Ayarze R: Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature. European Journal of Clinical Microbiology & Infectious Diseases (1992) 11:237-240
14. Chapman AJ, Musher DM, Jonsson S, Calridge JE, Wallace RJ: Development of bactericidal antibody during Branhamella catarrhalis infection. Journal of Infectious Diseases (1985) 151:878-882
15. Shurin PA, Marchant CD, Kim CH, Van Hare GF, Johnson CE, Tutihasi MA, Knapp LJ: Emergence of beta-lactamase producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatric Infectious Disease Journal (1983) 2:34-38
16. Calder MA, Croughan MJ, McLeod DT, Ahmad F: The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections. Drugs (1986) 31, Supplement 3:11-16
17. Davies BI, Maesen FPV: The epidemiology of respiratory tract pathogens in Southern Netherlands. European Respiratory Journal (1988) 1:415-420
18. Wright PW, Wallace RJ, Shepherd JR: A descriptive study of 42 cases of Branhamella catarrhalis pneumonia. American Journal of Medicine (1990) 88, Supplement 5A: 2-8
19. Chong CY, Lim WH, Heng JT, Chay OM: The changing trend in the pattern of infective etiologies in childhood acute lower respiratory tract infection. Acta Paediatrica Japonica (1997) 39:317-321
20. Henriksen SD: Moraxella, Neisseria, Branhamella and Acinetobacter. Annual Reviews of Microbiology (1976) 30:63-83
21. Blackwell C, Young H, Bain S: Isolation of Neisseria meningitidis and Neisseria catarrhalis from the genitourinary tract and anal canal. British Journal of Venereal Disease (1978) 54:41-44
22. Wilhelmus KR, Peacock J, Coster DJ: Branhamella keratitis. British Journal of Ophthalmology (1980) 64:892-895
23. Ingvarsson L, Lundgren K, Ursing J: The bacterial flora in the nasopharynx in healthy children. Acta Otolaryngology (1982) 386, Supplement: 94-96
24. Aniansson G, Alm B, Andersson B, Larsson P, Nylen O, Peterson H, Rigner P, Svanborg M, Svanborg C: Nasopharyngeal colonization during the first year of life. Journal of Infectious Diseases (1992) 165, Supplement 1:38-42
25. Ejlertsen T, Thisted E, Ebbesen F, Olesen B, Renneberg J: Branhamella catarrhalis children and adults. A study of prevalence, time of colonisation and association with upper and lower respiratory tract infections. Journal of Infection (1994) 29:23-31
26. Faden H, Harabuchi Y, Hong JJ: Epidemiology of Moraxella catarrhalis in children during the first two years of life: relationship to otitis media. Journal of Infectious Diseases (1994) 169:1312-1317
27. Ejlertsen T, Thisted E, Ostergaard PA, Renneberg J: Maternal antibodies and acquired serological response to Moraxella catarrhalis in children determined by an enzyme-linked immunosorbent assay. Clinical and Diagnostic Laboratory Immunology (1994) 1:464-468
28. Pollard JA, Wallace RJ, Nash DR, Luman JI, Wilson RW: Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs (1986) 31, Supplement 3:103-108
29. DiGiovanni C, Riley TV, Hoyne GF, Yeo R, Cooksey P: Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia. Epidemiology and Infection (1987) 99:445-453
30. Ejlertsen T: Pharyngeal carriage of Moraxella (Branhamella) catarrhalis in healthy adults. European Journal of Clinical Microbiology & Infectious Diseases (1991) 10:89
31. Klingman KL, Pye A, Murphy TF, Hill SL: Dynamics of respiratory tract colonization by Branhamella catarrhalis in bronchiectasis. American Journal of Respiratory and Critical Care Medicine (1995) 152:1072-1078
32. Van Hare GF, Shurin PA, Marchant CD, Cartelli NA, Johnson CE, Fulton D, Carlin S, Kim CH: Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Reviews of Infectious Diseases (1987) 9:16-27
33. Felmingham D, Gruneberg RN. The Alexander Project Group: A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project. Journal of Antimicrobial Chemotherapy (1996) 38, Supplement A: 1-57
34. West M, Berk SL, Smith JK: Branhamella catarrhalis pneumonia. Southern Medical Journal (1982) 75:1021-1023
35. Wallace RJ, Musher DM: In honor of Dr. Sarah Branham, a star is born. The realization of Branhamella catarrhalis as a respiratory pathogen. Chest (1986) 90:447-450
36. Bodkin S, Warde D: Moraxella catarrhalis - an unusual pathogen in bacterial tracheitis. British Medical Journal (1993) 86:208-209
37. Schalen L, Christensen P, Kamme C, Miorner H, Pettersson KI, Schalen C: High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scandinavian Journal of Infectious Diseases (1980) 12:277-280
38. Hol C, Schalen C, Verduin CM, Van Dijke EEM, Verhoef J, Fleer A, Van Dijk H: Moraxella catarrhalis in acute laryngitis: infection or colonization? Journal of Infectious Diseases (1996) 174:636-638
39. Brorson JE, Axelsson A, Holm SE: Studies on Branhamella catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scandinavian Journal of Infectious Diseases (1976) 8:151-155
40. Wald ER, Milmore GJ, Bowen AD, Ledesma-Medina J, Salamon N, Bluestone CD: Acute maxillary sinusitis in children. New England Journal of Medicine (1981) 304:749-754
41. Wald ER, Reilly JS, Casselbrant M, Ledesma-Medina J, Milmoe GJ, Bluestone CD, Chiponis D: Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor. Journal of Pediatrics (1984) 104:297-302
42. Goldenhersh MJ, Rachelefsky GS, Dudley J, Brill J, Katz RM, Rohr AS, Spector SL, Siegel SC, Summanen P, Baron EJ, Finegold S: The microbiology of chronic sinus disease in children with respiratory allergy. Journal of Allergy and Clinical Immunology (1990) 85:1030-1039
43. Penttila M, Savolainen S, Kiukaanniemi H, Forsblom B, Jousimiessomer H: Bacterial findings in acute maxillary sinusitis - European study. Acta Oto-Laryngologica (1997) Supplement 529:165-168
44. Brorson J, Malmvall B: Branhamella catarrhalis and other bacteria in the nasopharynx of children with long standing cough. Scandinavian Journal of Infectious Diseases (1981) 13:111-113
45. Gottfarb P, Brauner A: Children with persistent cough -outcome with treatment and role of Moraxella catarrhalis? Scandinavian Journal of Infectious Diseases (1994) 26:545-551
46. Tinkelman DG, Silk HJ: Clinical and bacteriologic features of chronic sinusitis in children. American Journal of Diseases of Children (1989) 143:938-941
47. Slevin NJ, Aitken J, Thornley PE: Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Lancet (1984) i: 782-783
48. Capewell S, McLeod DT, Croughan MJ, Ahmad F, Calder MA, Seaton A: Pneumonia due to Branhamella catarrhalis. Thorax (1988) 43:929-930
49. Barreiro B, Esteban L, Prats E, Verdaguer E, Dorca J, Manresa F: Branhamella catarrhalis respiratory infections. European Respiratory Journal (1992) 5:675-679
50. Chin NK, Kumarasinghe G, Lim TK: Moraxella catarrhalis respiratory infection in adults. Singapore Medical Journal (1993) 34:409-411
51. Arola M, Ruuskanen O, Ziegler T, Mertsola J, Nanto-Salonen K, Putto-Laurila A, Viljanen M K, Halonen P: Clinical role of respiratory virus infection in acute otitis media. Pediatrics (1990) 86:848-855
52. McNeely DJ, Kitchens CS, Kluge RM: Fatal Branhamella (Neisseria) catarrhalis pneumonia in an immunodeficient host. American Review of Respiratory Disease (1976) 114:399-402
53. Diamond LA, Lorber B: Branhamella catarrhalis pneumonia and immunoglobulin abnormalities: a new association? American Review of Respiratory Disease (1984) 129:876-878
54. Davies BI, Maesen FPV: Treatment of Branhamella catarrhalis infections. Journal of Antimicrobial Chemotherapy (1990) 25:1-7
55. Boyle FM, Georghiou PR, Tilse MH, McCormack JG: Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Medical Journal of Australia (1991) 154:592-596
56. Catlin B: Branhamella catarrhalis: an organism gaining respect as a pathogen. Clinical Microbiology Reviews. (1990) 3:293-320
57. Carr B, Walsh JB, Coakley D, Scott T, Mulvihill E, Keane C: Effect of age on adherence of Branhamella catarrhalis to buccal epithelial cells. Gerontology (1989) 35:127-129
58. Murphy S, Fitzgerald M, Mulcahy R, Keane C, Coakley D, Scott T: Studies on haemagglutination and serum resistance status of strains of Moraxella catarrhalis isolated from the elderly. Gerontology (1997) 43:277-282
59. Mannion PT: Sputum microbiology in a district general hospital. The role of Branhamella catarrhalis. British Journal of Diseases of the Chest (1987) 81:391-396
60. Ohlsson A, Bailey T: Neonatal pneumonia caused by Branhamella catarrhalis. Scandinavian Journal of Infectious Diseases (1985) 17:225-228
61. Haddad J, Faou AL, Simconi U, Messer J: Hospital-acquired bronchopulmonary infection in premature infants due to Branhamella catarrhalis. Journal of Hospital Infection (1986) 7:301-302
62. Berg RA, Bartley DL: Pneumonia associated with Branhamella catarrhalis in infants. Pediatric Infectious Disease Journal (1987) 6:569-573
63. Dyson C, Poonyth HD, Watkinson M, Rose SJ: Life threatening Branhamella catarrhalis pneumonia in young infants. Journal of Infection (1990) 21:305-307
64. Korppi M, Katila M L, Jaaskelainen J, Leinonen M: Role of Moraxella (Branhamella) catarrhalis as a respiratory pathogen in children. Acta Paediatrica (1992) 81:993-996
65. Berner R, Schumacher RF, Brandis M, Forster J: Colonization and infection with Moraxella catarrhalis in childhood. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15:506-509
66. Seddon PC, Sunderland D, O'Halloran SM, Hart CA, Heaf DP: Branhamella catarrhalis colonization in preschool asthmatics. Pediatric Pulmonology (1992) 13:133-135
67. Devalia JL, Grady D, Harmanyeri Y, Tabaqchali S, Davies RJ: Histamine synthesis by respiratory tract microorganisms: a possible role in pathogenicity. Journal of Clinical Pathology (1989) 42:516-522
68. McLeod DT, Ahmad F, Croughan MJ, Calder MA: Bronchopulmonary infection due to B. catarrhalis: clinical features and therapeutic response. Drugs (1986) 31, Supplement 3:109-112
69. Sarubbi FA, Myers JW, Williams JJ, Shell CG: Respiratory infections caused by Branhamella catarrhalis. Selected epidemiologic features. American Journal of Medicine (1990) 88, Supplement 5A: 5-9
70. Smith JMB, Lockwood BM: A 2-year survey of Branhamella catarrhalis in a general hospital. Journal of Hospital Infection (1986) 7:277-283
71. Mbaki N, Rikitome N, Nagatake T, Matsumoto K: Correlation between Branhamella catarrhalis adherence to oropharyngeal cells and seasonal incidence of lower respiratory tract infections. Tohoku Journal of Experimental Medicine (1987) 153:111-121
72. Kovatch AL, Wald ER, Michaels RH: Beta-lactamase producing Branhamella catarrhalis causing otitis media in children. Journal of Pediatrics (1983) 102:261-264
73. Bluestone CD: Otitis media and sinusitis in children. Role of Branhamella catarrhalis. Drugs (1986) 31, Supplement 3:132-141
74. Faden H, Bernstein J, Stanievich J, Drystofik D, Shuff C, Hong JJ, Ogra PL: Effect of prior antibiotic treatment on middle ear disease in children. Annals of Otology, Rhinology and Laryngology (1992) 10:87-41
75. Aspin MM, Hoverman A, McCarty J, McLinn SE, Aronoff S, Lang DJ, Arrieta A: Comparative study of the safety and efficacy of clarithromycin and amoxicillin-elavulanate in the treatment of acute otitis media in children. Journal of Pediatrics (1994) 125:135-141
76. Faden H, Brodsky L, Waz MJ, Stanievich J, Bernstein JM, Ogra PL: Nasopharyngeal flora in the first three years of life in normal and otitis prone children. Annals of Otology, Rhinology and Laryngology (1991) 100:612-615
77. Stenfors LE, Raisanen S: Secretory IgA-, IgG- and C3b-coated bacteria in the nasopharynx of otitis-prone and non-otitis-prone children. Acta Otolaryngology (1993) 113:191-195
78. Dickinson DP, Loos BG, Dryja DM, Bernstein JM: Restriction fragment mapping of Branhamella catarrhalis: a new tool for studying the epidemiology of this middle ear pathogen. Journal of Infectious Diseases (1988) 158:205-208
79. Prellner K, Christensen P, Hoveliu B, Rosen C: Nasopharyngeal carriage of bacteria in otitis-prone and non-otitis-prone children in day-care centres. Acta Otolaryngology (1984) 98:343-350
80. Faden H, Duffy L, Wasielewdki R, Wolf J, Drystofik D, Tung Y: Relationship between nasopharyngeal colonization and the development of otitis media in children. Journal of Infectious Diseases (1997) 175:1440-1445
81. Cook PP, Hecht DW, Snydman DR: Nosocomial Branhamella catarrhalis in a paediatric intensive care unit; risk factors for disease. Journal of Hospital Infection (1989) 13:299-307
82. McLeod DT, Ahmad F, Power JT, Calder MA, Seaton A: Bronchopulmonary infections due to Branhamella catarrhalis. British Medical Journal (1983) 287:1446-1447
83. Patterson TF, Patterson J E, Masecar BL, Barden GE, Hierholzer WJ, Zervos MJ: A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. Journal of Infectious Diseases (1988) 157:996-1001
84. Ikram RB, Nixon M, Aitken J, Wells E: A prospective study of isolation of Moraxella catarrhalis in a hospital during the winter months. Journal of Hospital Infection (1993) 25:7-14
85. Enright MC, McKenzie H: Moraxella (Branhamella) catarrhalis - clinical and molecular aspects of a rediscovered pathogen. Journal of Medical Microbiology (1997) 46:360-371
86. Ahmad F, McLeod DT, Power JT, Calder MA: Branhamella catarrhalis prevalence in a hospital population. Journal of Hospital Infection (1985) 6:71-74
87. Denamur E, Suermondt G, Debroca A, Defouilloy C, Laurans G, Muir JF, Orfila J: Nosocomial pulmonary infections caused by Branhamella catarrhalis in intensive care units. Agressologie (1989) 30:251-253
88. Richards SJ, Greening AP, Enright MC, Morgan MG, McKenzie H: Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax (1993) 48:91-92
89. McKenzie H, Morgan MG, Jordens JZ, Enright MC, Bain M: Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. Journal of Medical Microbiology (1992) 37:70-76
90. Christensen JJ, Bruun B: Bacteremia caused by a beta-lactamase producing strain of Branhamella catarrhalis. APMIS (1985) 93:273-275
91. Saito H, Ananissie J, Khardori N, Bodey GP: Branhamella catarrhalis septicemia in patients with leukemia. Cancer (1988) 61:2315-2317
92. Cimolai N, Adderley J: Branhamella catarrhalis bacteremia in children. Acta Pediatrica Scandanavia (1989) 78:465-468
93. Challier P, Vuthien H, Castaldi I: A review of four cases of bacteremia in children. Annales de Pediatrie (1990) 37:44-47
94. Domingo P, Puig M, Pericas R, Mirelis B, Prats G: Moraxella catarrhalis bacteraemia in an immunocompetent adult. Scandinavian Journal of Infectious Diseases (1995) 27:95
95. Ioannidis JPA, Worthington M, Greffiths JK, Snydman DR: Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clinical Infectious Diseases (1995) 21:390-397
96. Meyer GA, Shope TR, Waecker NJ, Lanningham FH: Moraxella (Branhamella) catarrhalis bacteremia in children. A report of two patients and review of the literature. Clinical Pediatrics (1995) 34:146-150
97. Cocchi P, Ulivelli A: Meningitis caused by Neisseria catarrhalis. Acta Pediatrica Scandanavia (1968) 57:451-453
98. Feign RD, San Joaqin V, Middelkamp JN: Purpura fulminans associated with Neisseria catarrhalis septicemia and meningitis. Pediatrics (1969) 44:120-123
99. Doern GV, Miller MJ, Winn RE: Branhamella (Neisseria) catarrhalis systemic disease in humans, case reports and review of the literature. Archives of Internal Medicine (1981) 141:1690-1692
100. Naqvi SH, Kilpatrick B, Bouhasin J: Branhamella catarrhalis meningitis following otolaryngologic surgery. APMIS (1988) Supplement 3:74-75
101. Daoud A, Abuekteish F, Masaadeh H: Neonatal meningitis due to Moraxella catarrhalis and review of the literature. Annals of Tropical Paediatrics (1996) 16:199-201
102. Heidemann DG, Alfonso E, Forster RK, Willman S, Holland SP, Mendelson A, Miller D: Branhamella catarrhalis keratitis. American Journal of Ophthalmology (1987) 103:576-581
103. Douer D, Danziger Y, Pinkhas J: Neisseria catarrhalis endocarditis. Annals of Internal Medicine (1977) 86:116
104. Turner HR, Taylor MR, Lockwood WR: Branhamella catarrhalis endocarditis in a patient receiving hemodialysis. Southern Medical Journal (1985) 78:1021-1022
105. Craig DB, Wehrle PA: Branhamella catarrhalis septic arthritis. Journal of Rheumatology (1983) 10:985-986
106. Ahmad F, McLeod DT, Croughan MJ, Calder MA: Urinary tract infection caused by Branhamella catarrhalis. Journal of Infection (1985) 10:176-177
107. Smith GL: Branhamella catarrhalis infection imitating gonorrhoeae in man. New England Journal of Medicine (1987) 316:1277
108. Elbasnier AM, Deshpande H: Recurrent urinary tract infection with haematuria caused by Moraxella (Branhamella) catarrhalis. Journal of Infection (1993) 27:216-217
109. MacArthur RD: Branhamella catarrhalis peritonitis in two continuous ambulatory peritoneal dialysis patients. Peritoneal Dialysis International (1990) 10:169-171
110. Dadone C, Redaelli B: Branhamella catarrhalis peritonitis in CAPD: an avoidable complication? Peritoneal Dialysis International (1991) 11:185
111. Contreras MR, Ash SR, Swick SD, Grutzner J: Peritonitis due to Moraxella (Branhamella) catarrhalis in a diabetic patient receiving peritoneal dialysis. Southern Medical Journal (1993) 86:589-590
112. Spark RP, Dahlberg PW, LaBelle JW: Pseudogonococcal Ophthalmia Neonatorum. Branhamella (Neisseria) catarrhalis conjunctivitis. American Journal of Clinical Pathology (1979) 72:471-473
113. Garvey RJP, Reed TAG: Ophthalmia neonatorum due to Branhamella (Neisseria) catarrhalis. British Journal of Venereal Disease (1981) 57:346-347
114. Righter J, Nicol G: Branhamella catarrhalis conjunctivitis. Canadian Medical Association Journal (1983) 128:955-956
115. Sanchez F, Navarro F, Coll P: Neonatal conjunctivitis caused by Moraxella (Branhamella) catarrhalis. Enfermedades Infecciosas Y Microbiologia Clinica (1991) 7:291
116. Weiss A, Brinser JH, Nazar-Stewart V: Acute conjunctivitis in childhood. Journal of Pediatrics (1993) 122:10-14
117. Berk SL, Kalbfleisch JH, The Alexander Project Collaborative Group: Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA. Journal of Antimicrobial Chemotherapy (1996) 38 Supplement A: 85-96
118. Barber M, Waterworth PM: Antibacterial activity of the penicillins. British Medical Journal (1962) 1:1159-1163
119. Catlin BW: Transfer of the organism named Neisseria catarrhalis to Branhamella gen. nov. International Journal of Systematic Bacteriology (1970) 20:155-159
120. Kamme C: Evaluation of the in vitro sensitivity of Neisseria catarrhalis to antibiotics with respect to acute otitis media. Scandinavian Journal of Infectious Diseases (1970) 2:117-120
121. Malmvall B, Brorsson J, Johnsson J: In vitro sensitivity of penicillin V and β-lactamase production of Branhamella catarrhalis. Journal of Antimicrobial Chemotherapy (1977) 3:374-375
122. Ninane G, Joly J, Piot P, Kraytman M: Branhamella (Neisseria) catarrhalis as a pathogen. Lancet (1977) ii: 149
123. Percival A, Corkill J E, Rowlands J, Sykes RB: Pathogenicity of and β-lactamase production by Branhamella (Neisseria) catarrhalis. Lancet (1977) ii: 1175
124. Doern GV, Brueggemann AB, Pierce G, Hogan T, Holley HP, Rauch A: Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the Unites States in 1994 and 1995: results of a 30-centre national surveillance study. Antimicrobial Agents and Chemotherapy (1996) 40:2884-2886
125. Wood G M, Johnson BC, McCormack JG: Moraxella catarrhalis: Pathogenic significance in respiratory tract infections treated by community practitioners. Clinical Infectious Diseases (1996) 22:632-636
126. Farmer T, Reading C: β-lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrobial Agents and Chemotherapy (1982) 21:506-508
127. Kallings I, Bengtsson S, Christensen P, Holm SE, Lind L, Kalin M: Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scandinavian Journal of Infectious Diseases (1983) Supplement 39:100-105
128. Wallace RJ, Nash DR, Steingrube VA: Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. American Journal of Medicine (1990) 88, Supplement 5A: 46-50
129. Fung CP, Powell M, Seymour A, Yuan M, Williams JD: The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991. Journal of Antimicrobial Chemotherapy (1992) 30:47-55
130. Ahmad F, McLeod DT, Croughan MJ, Calder MA: Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections. Antimicrobial Agents and Chemotherapy (1984) 26:424-425
131. Doern GV, Tubert TA: In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different susceptibility test methods. Antimicrobial Agents and Chemotherapy (1988) 32:259-261
132. Nash DR, Flanagan C, Steele LC, Wallace RJ: Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae. Antimicrobial Agents and Chemotherapy (1991) 35:192-194
133. Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, Nicoletti G: In vitro activity of a new broad spectrum β-lactamase stable oral cephalosporin cefixime, in comparison with other drugs, against Haemophilus influenzae. Haemophilus parainfluenzae. Moraxella catarrhalis and Streptococcus pneumoniae. Chemotherapy (1992) 38:36-45
134. Felmingham D, Robbins MJ, Dencer C, Nathwani A, Grunberg RN: Antimicrobial susceptibility of community-acquired bacterial lower respiratory tract pathogens. Journal of Antimicrobial Chemotherapy (1996) 28:747-751
135. Luman I, Wilson RW, Wallace RJ, Nash DR: Disk diffusion susceptibility of Branhamella catarrhalis and relationship of β-lactam zone size to β-lactamase production. Antimicrobial Agents and Chemotherapy (1986) 30:774-776
136. Seto WH, Yuen KY: The successful treatment of Branhamella catarrhalis bronchopulmonary infections in adults with amoxycillin. Journal of Antimicrobial Chemotherapy (1991) 27:146-147
137. Louie MH, Gabay EL, Mathison GE, Finegold SM: Branhamella catarrhalis pneumonia. Western Journal of Medicine (1983) 138:47-49
138. Bogaerts J, Lepage P, Vande Weghe JP, Vandepitte J: Severe respiratory infection with Branhamella catarrhalis in an African child. European Journal of Pediatrics (1985) 143:303-304
139. Ejlertsen T, Skov R: The β-lactamase of Moraxella (Branhamella) catarrhalis isolated from Danish children. APMIS (1996) 104:557-562
140. Motte S, Derruys E, Thys J: Therapeutic failure due to Branhamella catarrhalis in pneumococcal pneumonia. Chest (1987) 92:382-383
141. Livermore DM: β-Lactamases in laboratory and clinical resistance. Clinical Microbiological Reviews (1995) 8:557-584
142. Doern GV, Siebers KG, Hallick LM, Morse SA: Antibiotic susceptibility of beta-lactamase producing strains of Branhamella (Neisseria) catarrhalis. Antimicrobial Agents and Chemotherapy (1980) 17:24-29
143. Farmer T, Reading C: Inhibition of the β-lactamase of Branhamella catarrhalis by clavulanic acid and other inhibitors. Drugs (1986) 31, Supplement 3:70-78
144. Slocombe B: Inhibition of β-lactamases in Branhamella catarrhalis. Drugs (1986) 31, Supplement 3:79-81
145. Wallace RJ, Steele LC, Brooks DL, Luman JI, Wilson RW, McLarty JW: Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis. Antimicrobial Agents and Chemotherapy (1985) 27:912-915
146. Marchant CD, Shurin PA, Johnson CE, Murdell-Panek D, Feinstein JC, Fulton D, Flexon P, Carlin SA, Van Hare GF: A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. Journal of Pediatrics (1986) 109:891-896
147. Wardle JK: Branhamella catarrhalis as an indirect pathogen. Drugs (1986) 31, Supplement 3:93-96
148. Kaiser L, Lew D, Hirschel B, Auckenthaler R, Morabia A, Heald A, Benedict P, Terrier F, Wunderli W, Matter L, Germann D, Voegeli J, Stalder H: Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet (1996) 347:1507-1510
149. Thornley PE, Aitken JM, Nichol GM, Slevin NJ: Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to β-lactamase producing Branhamella catarrhalis: preliminary report. Drugs (1986) 31, Supplement 3:113-114
150. Robledano L, Rivera MJ, Otal I, Gomez-lus R: Enzymatic modification of aminoglycoside antibiotics by Branhamella catarrhalis carrying an R factor. Drugs under Experimental and Clinical Research (1987) 13:137-143
151. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS: Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy (1990) 34:2075-2080
152. Gotoh N, Tanaka S, Nishino T: Supersusceptibility to hydrophobic antimicrobial agents and cell surface hydrophobicity in Branhamella catarrhalis. FEMS Microbiology Letters (1989) 59:211-214
153. Alvarez S, Jones M, Holtsclaw-Berk S, Guarderas J, Berk SL: In vitro susceptibilities and β-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrobial Agents and Chemotherapy (1985) 27:646-647
154. Sweeney KG, Berghese A, Needham CA: In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonising strains. Antimicrobial Agents and Chemotherapy (1985) 27:499-502
155. Brown BA, Wallace RJ, Flannagan CW, Wilson RW, Luman JI, Redditt R: Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis. Antimicrobial Agents and Chemotherapy (1989) 33:1631-1633
156. Spencer RC, Wheat PF: In vitro activity of roxithromycin against Branhamella catarrhalis. Journal of Antimicrobial Chemotherapy (1990) 26:153-154
157. Zheng X, Cao Y: Beta-lactamase producing Branhamella in Beijing, China. Pediatric Infectious Disease Journal (1988) 7:744
158. Roberts MC, Brown BA, Steingrube VA, Wallace RJ: Genetic basis of tetracycline resistance in Moraxella (Branhamella) catarrhalis. Antimicrobial Agents and Chemotherapy (1990) 34:1816-1818
159. Roberts MC, Pang Y, Spencer RC, Winstanley TG, Brown BA, Wallace RJ: Tetracycline resistance in Moraxella (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis. Antimicrobial Agents and Chemotherapy (1991) 35:2453-2455
160. Gomez J, Ruiz-Gomez J, Hernandez-Cardona JL, Nunez ML, Cameras M, Valdes M: Antibiotic resistance patterns of Streptococcus pneumoniae. Haemophilus influenzae and Moraxella catarrhalis: A prospective study in Murcia, Spain, 1983-1992. Chemotherapy (1994) 40:299-303
161. Schalen L, Eliasson I, Kamme C, Schalen C: Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology and Laryngology (1993) 102:209-214
162. Klein NC: Fluoroquinolones in respiratory infections. Seminars in Respiratory Infection (1991) 6:131-135
163. Bourgeois F, Bingen E: Killing kinetics of five fluoroquinolones against Moraxella catarrhalis at clinically achievable concentrations. Journal of Antimicrobial Chemotherapy (1994) 33:364-365
164. Hoogkamp-Korstanje JAA: In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, oflxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections. Journal of Antimicrobial Chemotherapy (1997) 40:427-431
165. Forsgren A, Walder M: Antimicrobial susceptibility of bacterial isolates in South Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS (1994) 102:227-235
166. Cunliffe NA, Emmanuel FXS, Thomson CJ: Lower respiratory tract infection due to ciprofloxacin resistant Moraxella catarrhalis. Journal of Antimicrobial Chemotherapy (1995) 36:273-274
167. Buu Hoi-Dang Van A, Brive-Le Bouquence B, Barthelemy M, Labia R: Novel β-lactamases from Branhamella catarrhalis. Annals of Microbiology (1978) 129B: 6-10
168. Simpson IN, Plested SJ: The origin and properties of β-lactamase satellite hands seen in isoelectric focusing. Journal of Antimicrobial Chemotherapy (1983) 12:127-131
169. Kamme C, Vang M, Stahl S: Intrageneric and intergeneric transfer of Branhamella catarrhalis beta-lactamase production. Scandinavian Journal of Infectious Diseases (1984) 16:153-155
170. Wallace RJ, Vincent JR, Steingrube VA, Nash DR, Hollis DG, Flanagan C, Brown BA, Labidi A, Weaver RE: BRO β-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal β-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Antimicrobial Agents and Chemotherapy (1989) 33:1845-1854
171. Eliasson I, Kamme C: Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity. Journal of Antimicrobial Chemotherapy (1985) 15:139-149
172. Bootsma HJ, van Dijk H, Verhoef J, Fleer A, Mooi FR: Molecular characterization of the BRO β-lactamases of Moraxella (Branhamella) catarrhalis. Antimicrobial Agents and Chemotherapy (1996) 40:966-972
173. Christensen JJ, Keiding J, Schumacher H, Bruun B: Recognition of a new Branhamella catarrhalis β-lactamase - BRO-3. Journal of Antimicrobial Chemotherapy (1991) 28:774-775
174. Christensen JJ, Keiding JJ, Bruun B: Antimicrobial susceptibility and β-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988. APMIS (1990) 98:1039-1044
175. Philippon A, Riou JY, Guibourdenche M, Sotolongo F: Detection, distribution and inhibition of Branhamella catarrhalis β-lactamase. Drugs (1986) 31, Supplement 3:64-69
176. Stobberingh EE, Davies BI, van Boven CPA: Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases. Journal of Antimicrobial Chemotherapy (1984) 13:55-64
177. Eliasson I, Kamme C, Prellner K: Beta-lactamase production in the upper respiratory tract flora. European Journal of Clinical Microbiology & Infectious Diseases (1986) 5:507-512
178. Fung C, Jang T, Liu C, Lau Y, Liu Y, Chuang V, Lee N: Antimicrobial susceptibility and β-lactamase production of Moraxella catarrhalis isolates in Taiwan. Journal of the Formos Medical Association (1996) 91:548-554
179. Manninen R, Huovinen P, Nissinen A, The Finnish Study Group for Antimicrobial Resistance: Increasing Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland. Journal of Antimicrobial Chemotherapy (1997) 40:387-392
180. Nash DR, Wallace RJ, Steingrube VA, Shurin PA: Isoelectric focusing of β-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States. Drugs (1986) 31, Supplement 3:48-54
181. Eliasson I, Kamme C, Vang M, Waley SG: Characterization of cell-bound papain-soluble β-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens. European Journal of Clinical Microbiology & Infectious Diseases (1992) 11:313-321
182. Ikeda F, Yokota Y, Mine Y, Yamada T: Characterization of BRO enzymes and beta-lactamase transfer of Moraxella (Branhamella) catarrhalis isolated in Japan. Chemotherapy (1993) 39:88-95
183. Fung C, Yeo S, Livermore DM: Susceptibility of Moraxella catarrhalis isolates to β-lactam antibiotics in relation to β-lactamase pattern. Journal of Antimicrobial Chemotherapy (1994) 33:215-222
184. Chaibi EB, Mugnier P, Kitzis MD, Goldstein RW, Acar JF: Branhamella catarrhalis β-lactamases and their phenotypic implication. Research in Microbiology (1995) 146:761-771
185. Doern GV, Tubert TA: Effect of inoculum size on results of macrotube dilution susceptibility test with Branhamella catarrhalis. Journal of Clinical Microbiology (1987) 25:1576-1578
186. Jones RN, Sommers HM: Identification and antimicrobial susceptibility testing of Branhamella catarrhalis in United States laboratories, 1983-1985. Drugs (1986) 31, Supplement 3:34-37
187. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. Edition 6. NCCLS Document M100-S6. NCCLS, Villanova (1995)
188. Doern GV, Tubert TA: Detection of β-lactamase activity among clinical isolates of Branhamella catarrhalis with six different β-lactamase assays. Journal of Clinical Microbiology (1987) 25:1380-1383
189. Yeo SF, Livermore DM: Effect of inoculum size on the in-vitro susceptibility to β-lactam antibiotics of Moraxella catarrhalis isolates of different β-lactamase types. Journal of Medical Microbiology (1994) 40:252-255
190. Roques C, Roux I, Hababi L, Federlin M, Michel G: In vitro activity of oral β-lactams against 40 β-lactamase producing strains of Branhamella (Moraxella) catarrhalis correlated to the inoculum size. Medecine et Maladies Infectieuses (1997) 27:774-777
191. Thickett KJ, Winstanley TG: Multipoint microbiological assay for detecting beta-lactamase. Journal of Clinical Pathology (1991) 44:435-436
192. Peiris V: Detection of β-lactamase production in Moraxella catarrhalis. Journal of Antimicrobial Chemotherapy (1992) 30:399
193. Labia R, Barthelemy M, Brive Le Bouguennec C, Buu Hoi-Dang Van A: Classification of β-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species. Drugs (1986) 31, Supplement 3:40-47
194. Stobberingh EE, van Eck HJ, Houben AW, van Boven CPA: Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis. Drugs (1986) 31, Supplement 3:23-27
195. Bedenic B, Zagar Z: Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid. Journal of Chemotherapy (1994) 6:383-387
196. Bush K, Jacoby GA, Medeiros AA: A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy (1995) 39:1211-1233
197. Yokota E, Fujii T, Sato K, Inque M, Mitsuhashi S: Purification and properties of beta-lactamase produced by Branhamella catarrhalis. Antimicrobial Agents and Chemotherapy (1986) 29:696-698
198. Pollock MR: Purification and properties of penicillinases from two strains of Bacillus licheniformis: a chemical, physiochemical and physiological comparison. Biochemical Journal (1965) 94:666-675
199. Livermore D: Enzymes involved in bacterial resistance to β-lactams and other antibiotics. In: Proceedings of the Symposium on Antibiotic Resistance and Cross Resistance. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1986. Hospital Practice Publication (1987) p. 23-27
200. Steingrube VA, Wallace RJ, Beaulieu D: A membrane-bound precursor β-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 β-lactamases. Journal of Antimicrobial Chemotherapy (1993) 31:237-244
201. Cooper CE, Slocombe B, White AR: Effect of low concentrations of clavulanic acid on the invitro activity of amoxycillin against β-lactamase producing Branhamella catarrhalis and Haemophilus influenzae. Journal of Antimicrobial Chemotherapy (1990) 26:371-380
202. Matthew M, Harris AM, Marshall MJ, Ross GW: The use of analytical isoelectric focusing for detection and identification of β-lactamases. Journal of General Microbiology (1975) 88:169-178
203. Yamamoto S, Lampen LO: Purification of plasma membrane penicillinase for Bacillus licheniformis 749/C and comparison with exoenzyme. Journal of Biological Chemistry (1976) 251:4095-4101
204. Sykes RB, Georgopapadakou NK: Bacterial resistance to β-lactam antibiotics: an overview. In: Salton MRJ, Shockman GD (ed): Beta-lactam antibiotics: mode of action, new developments, and future prospects. Academic Press (1981) p. 199-214
205. Livermore DM, Chai PY, Wong AIW, Leung YK: β-lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance. Journal of Antimicrobial Chemotherapy (1987) 20:313-321
206. Foweraker JE, Hawkey PM, Heritage J, Van Landuyt HW: Novel β-lactamase from Capnocytophaga species. Antimicrobial Agents and Chemotherapy (1990) 34:1501-1504
207. Spratt BG, Cromie KD: Penicillin-binding proteins of gram-negative bacteria. Reviews of Infectious Diseases (1988) 10:699-711
208. Pluckthun A, Pfitzinger I: Membrane-bound β-lactamase forms in Escherichia coli. Journal of Biological Chemistry (1988) 263:14315-14322
209. Piot P, Roberts M, Ninane G: β-Lactamase production in commensal Neisseriacea. Lancet (1979) i: 619
210. van Embden JDA, van Klingeren B, Dessens-Kroon M, van Wijngaarden LJ: Penicillinase-producing Neisseria gonorrhoeae in the Netherlands: Epidemiology and genetic and molecular characterization of their plasmids. Antimicrobial Agents and Chemotherapy (1980) 18:789-797
211. Johnson MA, Drew WL, Roberts M: Branhamella (Neisseria) catarrhalis - a lower respiratory tract pathogen? Journal of Clinical Microbiology (1981) 13:1066-1069
212. Kamme C, Vang M, Stahl S: Transfer of β-lactamase production in Branhamella catarrhalis. Scandinavian Journal of Infectious Diseases (1983) 15:255-256
213. Kamme C, Eliasson I, Knutson BK, Vang M: Plasmid-mediated β-lactamase in Branhamella catarrhalis. Drugs (1986) 31, Supplement 3:55-63
214. Beaulieu D, Ouellette M, Bergeron MG, Roy PH: Characterization of a plasmid isolated from Branhamella catarrhalis and detection of plasmid sequences within the genome of a Branhamella catarrhalis strain. Plasmid (1988) 20:158-162
215. Schaberg DR, Zervos MJ: Intergenic and interspecies gene exchange in gram positive cocci. Antimicrobial Agents and Chemotherapy (1986) 30:817-822
216. Clewell DB, Flannagan SE: The conjugative transposons of gram-positive bacteria. In: D.B. Clewell (ed.): Bacterial conjugation. Plenum Press, New York (1993) p. 369-394
217. Roberts MC: Characterisation of the TetM determinants in urogenital and respiratory pathogens. Antimicrobial Agents and Chemotherapy (1990) 34:476-478
218. Scott JR, Churchward GG: Conjugative transposition. Annual Reviews of Microbiology (1995) 49:367-397
219. Macrina FL: Conjugal transfer in anaerobic bacteria. In: D.H. Clewell (ed.): Bacterial conjugation. Plenum Press, New York, (1993) p. 331-348
220. Catlin BW: Reciprocal genetic transformation between Neisseria catarrhalis and Moraxella nonliquefaciens. Journal of General Microbiology (1964) 37:369-379
221. Bovre K: Studies on transformation in Moraxella and organisms assumed to be related to Moraxella. 5. Streptomycin resistance transformation between serum-liquefying, nonhaemolytic moraxellae. Moraxella bovis and Moraxella nonliquefaciens. Acta Pathologica et Microbiologica Scandinavica (1965) 65:435-449
222. Dorward DW, Garon CF, Judd RC: Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoea. Journal of Bacteriology (1989) 171:2499-2505
223. Johnson KG, McDonald IJ, Perry MB: Studies on the cellular and free lipopolysaccharides from Branhamella catarrhalis. Canadian Journal of Microbiology (1976) 22:460-467
224. Hellio R, Guibourdenche M, Collatz E, Riou JY: The envelope structure of Branhamella catarrhalis as studied by transmission electron microscopy. Annales de l'Institut Pasteur - Microbiology (1988) 139:515-525
225. Murphy TF, Loeb MR: Isolation of the outer membrane of Branhamella catarrhalis. Microbial Pathogenesis (1989) 6:159-174
226. Molstad S, Eliasson I, Hovelius B, Kamme C, Schalen C: Beta-lactamase production in the upper respiratory tract flora in relation to antibiotic consumption: a study in children attending day nurseries. Scandinavian Journal of Infectious Diseases (1988) 20:329-334
227. Molstad S, Arvidsson E, Eliasson I, Hovelius B, Kamme C, Schalen C: Production of beta-lactamase by respiratory tract bacteria in children: relationship to antibiotic use. Scandanavian Journal of Primary Health Care (1992) 10:16-20